Fulcrum Therapeutics, Inc. (FULC) News

Fulcrum Therapeutics, Inc. (FULC): $3.21

0.05 (+1.58%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

B

Add FULC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#27 of 328

in industry

Filter FULC News Items

FULC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest FULC News From Around the Web

Below are the latest news stories about FULCRUM THERAPEUTICS INC that investors may wish to consider to help them evaluate FULC as an investment opportunity.

APP Stock Price Predictions: Is AppLovin Really Worth $50?

Applovin (APP) stock is in the news Tuesday after the stock got a new price target from Jefferies analyst Andrew Uerkwitz.

William White on InvestorPlace | August 22, 2023

BLNK Stock Alert: Blink Charging Signs Deal to Bring EV Charging to McDonald’s

Blink Charging (BLNK) stock is on the move Tuesday after the EV charging company signed a deal that brings its services to McDonald's (MCD).

William White on InvestorPlace | August 22, 2023

Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today?

Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate.

William White on InvestorPlace | August 22, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!